EXCLUSIVE: US refusals of crucial newborn vitamin spike, raising risk of dangerous bleeding

A sharp increase in the refusal of newborn vitamin K shots has been documented across the United States. According to reports from Medical Daily and NewsNation, the share of newborns leaving hospitals without this specific injection has risen by 57 percent since January. This trend involves parents declining a medical intervention that is considered crucial for preventing severe bleeding in infants. The data regarding this rising rate of non-receipt of vitamin K spans from 2019 through June 2026, as noted by Truveta. Multiple media outlets are emphasizing the clinical risks associated with this trend. Reuters, TimesLIVE, and the Honolulu Star-Advertiser all highlight that these refusals raise the risk of dangerous and severe bleeding.

Health and Me specifically notes that the absence of the vitamin K shot can lead to brain bleeding in newborns. This surge in refusals is being reported by a wide array of sources including Consultant360, Yahoo, and graziamagazine.com, while Yahoo Health reports that doctors are actively urging parents to ensure their newborns receive the shot. Contextual reports suggest a broader shift in parental attitudes toward newborn medical care. The Independent connects the soar in shot refusals to a health shake-up involving Trump and RFK Jr. Additionally, tovima.com reports that individuals identified as anti-vaxxers are now extending their refusals to include the newborn vitamin K shot. This trend is not limited to vitamins; Healio reports a simultaneous 107% jump in parental refusal of the newborn HBV vaccine, with some experts warning that a resurgence of related health issues is likely to follow.

Future monitoring will focus on the clinical outcomes of this trend as pediatricians express their concerns. The Lufkin Daily News indicates that pediatricians on the frontlines are currently weighing in on these key concerns. Medical professionals continue to monitor the gap between hospital discharge and the administration of the vitamin K shot to mitigate the risk of infant bleeding. Observers will be watching to see if the 57 percent jump reported since January continues to climb or if public health interventions can reverse the current trajectory.